Abstract
At present, there is no agreement on poor ovarian response definition, and no definitive evidence that this prognosis can be changed by a specific protocol. Our data suggest that a flare-up protocol with a depot gonadotropin-releasing hormone (GnRH) agonist formulation gives higher total pregnancy and implantation rates than a GnRH antagonist, possibly by improving oocyte/embryo competence.
MeSH terms
-
Adult
-
Chorionic Gonadotropin / pharmacology
-
Clinical Protocols*
-
Dose-Response Relationship, Drug
-
Embryo Transfer
-
Embryonic Development / physiology*
-
Female
-
Gonadotropin-Releasing Hormone / agonists*
-
Gonadotropin-Releasing Hormone / antagonists & inhibitors*
-
Humans
-
Luteolytic Agents / pharmacology
-
Oocytes / drug effects
-
Oocytes / physiology*
-
Ovulation Induction / methods*
-
Pregnancy
-
Pregnancy Rate
-
Retrospective Studies
-
Sperm Injections, Intracytoplasmic
-
Triptorelin Pamoate / pharmacology
Substances
-
Chorionic Gonadotropin
-
Luteolytic Agents
-
Triptorelin Pamoate
-
Gonadotropin-Releasing Hormone